Lataa...
Treatment options for vasomotor symptoms in menopause: focus on desvenlafaxine
Vasomotor symptoms (VMS), including hot flashes and night sweats, occur in as many as 68.5% of women as a result of menopause. While the median duration of these symptoms is 4 years, approximately 10% of women continue to experience VMS as many as 12 years after their final menstrual period. As such...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2012
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410701/ https://ncbi.nlm.nih.gov/pubmed/22870045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJWH.S24614 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|